Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Horizon Therapeutics PLC

NAS: HZNP

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Horizon Therapeutics PLC

Market open

 --Real time quotes

May 24, 2022, 11:55 a.m.

HZNP
/zigman2/quotes/206690250/composite

$

88.75

Change

+1.37 +1.57%

Volume

Volume 587,588

Real time quotes

/zigman2/quotes/206690250/composite

Previous close

$ 87.38

$ 88.75

Change

+1.37 +1.57%

Day low

Day high

$87.12

$89.45

Open

52 week low

52 week high

$82.51

$120.54

Open
Insider Activity Individual

Daniel A. Camardo

Transactions

Date Shares Transaction Value
04/05/2021 509   Derivative/Non-derivative trans. at $15.23 per share. 7,752
04/05/2021 15,467   Derivative/Non-derivative trans. at $25.52 per share. 394,717
04/05/2021 2,305   Derivative/Non-derivative trans. at $17.19 per share. 39,622
03/30/2021 3,517   Disposition at $86.87 per share. 305,522
03/30/2021 2,986   Disposition at $85.88 per share. 256,438
03/30/2021 4,594   Disposition at $84.97 per share. 390,353
03/30/2021 1,803   Disposition at $83.58 per share. 150,695
02/21/2021 576   Derivative/Non-derivative trans. at $88.87 per share. 51,190
02/21/2021 1,300   Derivative/Non-derivative trans. at $0 per share. 0
01/21/2021 1,427   Derivative/Non-derivative trans. at $77.43 per share. 110,493
01/21/2021 3,220   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2021 9,230   Derivative/Non-derivative trans. at $73.28 per share. 676,375
01/05/2021 20,614   Derivative/Non-derivative trans. at $0 per share. 0
11/06/2020 3,500   Disposition at $76.76 per share. 268,660
10/01/2020 4,460   Derivative/Non-derivative trans. at $80.42 per share. 358,674
10/01/2020 10,000   Award at $0 per share. 0
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.